The SARMs Research Collective  ·  Monitoring 14 compounds across 59 jurisdictions  ·  Literature tracked daily  ·  Evidence‑graded  ·  Est. MMXXVI
· SARMS INSTITUTE · SCIENTIA · LEX · EVIDENTIA ·SISARMS InstituteThe SARMs Research Collective
Research & Analysis

ACP-105 for Women: What the Research Actually Shows

ACP-105 is an experimental, unapproved selective androgen receptor modulator whose only controlled data in female animals come from a single neurocognitive study in irradiated mice, so claims about its use in women for muscle, bone, or fat loss are not supported by the published evidence.

SARMS Institute Research Desk. Compiled from primary sources. Last updated 20 July 2026.
This page is for education and does not provide medical or legal advice. No SARM is approved for human use.